How Cannabis Helps Your Body Eliminate Cancer Cells

By Nurse Lauren with Leonard Leinow

Our bodies are perfectly curated systems of tissues, organs, vasculature and more, that are all programmed to work in symphony to conduct the magic that we call being alive. Our cells are the building blocks of which the palaces of our being are built, and it is important to know a few basic processes that are fundamental for understanding how it all works. When we are taking any type of medication or doing any type of therapy it is crucial to understand the process by which it affects your body. When people comprehend their own bodies something extraordinary occurs, they become empowered about their health! They no longer feel like powerless victims floating through a sea of confusion, but rather informed participants making thoughtful decisions. How wonderful!

         As we all know, our bodies are made up of innumerable cells of all types and purposes. On the surface of every single one of them (including cancer cells) are various different receptors that receive compounds that initiate chemical reactions. Pertinent to our discussion here are the cannabinoid receptors, which are responsible for allowing our cells to interact with the various forms of CBD and THC found in cannabis. It is important to note here just how long our species (homo sapiens) had to exist alongside cannabis for our bodies to evolve receptors specifically for its molecules on our cells! It is compound that is crucial to our health and happiness, and this very fact shows us this.

         Researchers have identified two cannabinoid receptors thus far that exist in the bodies of mammals. The first is CB1, the most abundant receptor, which is predominantly found in the nervous system, connective tissues, gonads, glands, and organs. The second is CB2, which is predominantly present in the digestive and immune systems and its associated structures. Many tissues contain both CB1and CB2 receptors, each linked to a different action within the cell. Tumor cells have cannabinoid receptors on their surfaces as well. When THC and CBD bind to the receptors on tumor cells they create apoptotic, anti-proliferative, and anti-invasive results. Simply put, THC and CBD can induce cell suicide in a cancer cell. They can also slow cancer’s growth and spread by interrupting processes that it needs to survive.

         In a recent study conducted by St George’s University of London it was shown that THC, CBD and CBG are a potent combination in the fight against certain cancers. Preliminary studies like these are so important, as their results initiate further studies globally about cannabis and the human body. It takes many studies over many years before anything is ever widely accepted in medicine. These steps are crucial in educating everyone to the healing properties of cannabis at a scholarly level. In order to get these medicinal compounds to those that need them most we must study and spread the knowledge accordingly. Hooray for science!

         This is a good enough time as any to begin your healing journey with cannabis. Introducing a CBD and/or THC regimen into your life will assist your endocannabinoid system with lowering inflammation as a whole throughout your body. If you currently are dealing with cancer then the pain relieving and relaxing properties of THC and CBD should be considered as well. Cannabis assists with taking stress levels down so the body can rest and heal. It also boosts the immune system, needed to  restore health and stop the growth of cancer cells. There are innumerable reasons to take nature’s medicine, hopefully now you all understand a little bit more about how it works in your bodies.

In order to have effective cannabis medicine for this metabolic disorder, large doses of full spectrum CBD, THC and CBG are required. Synergy Wellness produces products designed for this purpose. Specifically, high dose suppositories are used, since administered this way, the medicine does not produce psychoactive side effects. Plus, suppositories are absorbed through the lymphatic system and delivered throughout the body, where needed.

Sending love to all on their healing journeys,

Nurse Lauren, BSN

Golden Nuggets from the Society of Cannabis Clinicians

by Ruth Hill RN BSN MAT CHPN

Anyone still wondering if cannabis is safe and medicinally effective must be living under a rock. Social media is now exploding with posts on the medicinal efficacy of cannabis. Physicians and nurses are recommending cannabis treatment. Medicinal cannabis organizations are expanding. To feel this excitement scroll the web pages of the Society of Cannabis Clinicians (SCC), and the American Cannabis Nurse Association (ACNA). Cannabis users are piercing through the propaganda bubble of the FDA. 

This article will expound on this excitement by reporting on the first conference of the SCC held at UCLA on September 2, 2023, cohosted by the Releaf Institute. Expert physicians presented cannabis as a first-line alternative treatment to unmanageable stubborn symptoms not responding to pharmaceuticals, the very definition of a refractory disease.  

Bonnie Goldstein MD, a pediatrician, kicked off the first lecture by describing the Endocannabinoid System (ECS). The ECS is a homeostatic regulatory system active throughout the brain and body, discovered in the 1990s by Rafael Mechoulam, an Israeli chemist.  The ECS is an adaptive response to cellular stress, it also maintains cellular homeostasis, fine-tunes synaptic transmission, and mediates synaptic plasticity. Most attendees had a basic knowledge of the ECS, but Dr. Goldstein took us on a deep dive into the chemistry and physiology of this newly discovered system. 

Dr. Genester Wilson-King lectured on Cannabis and Endometriosis. Wilson-King wasted no time in her condemnation of the overt bias of the medical industry toward Black women. This bias results in gross underdiagnosis of a malignant condition unresponsive to current treatment. Endometriosis has a 44% recurrence with medical treatment and a 55% recurrence with surgical treatment. Studies show cannabidiol (CBD) stops the migration of endometrial cells and resolves insomnia, nausea, pain, and dysmenorrhea.  

Dr. Patricia Frye presented the use of cannabinoids in the treatment of Autism Spectrum Disorder (ASD). The incidence of ASD is 2.76% of the U.S. population (9.6 million). In the year 2000, the incidence was 1:150. In 2020 the incidence exploded to 1:36. Researchers found children with ASD have low anandamide levels (endogenous THC). Dr. Frye used graphs to illustrate the extraordinary research on biomarkers developed by Goldstein for ASD.

Goldstein returned to the dais and revealed another U.S. patent on cannabis paid for by American taxpayers. The patent is on cannabidivarin (CBDV). It states that CBDV together with tetrahydrocannabivarin (THCV) far outperforms the use of pharmaceuticals for seizure disorders. The current practice of stacking one antiseizure drug after another induces side effects manifested by the child’s abhorrent behavior. After noticing a response, Goldstein’s treatment slowly tapers children off the multiple antiseizure drugs. There is NO research that verifies the efficacy of stacking antiseizure drugs. So, why do neurologists practice this?

Because trial and error use of pharmaceuticals often fails, how then do we palliate these women and children? Denying the use of cannabis as a first-line treatment is cruel and inhumane. This was emphasized over and over by our expert medical cannabis physicians. CBD has shown these drugs can be reduced by 56%. The research is there. Avoid sugar, lose weight, and focus on nutritional wellness instead of disease. 

We got our druthers twisted by Dr. Tim Fong who revealed how ineffective physicians are in diagnosing and managing Cannabis Use Disorder (CUD). If I knew someone with CUD, I would refer them to Dr Fong. He presented a long list of medications with dosages that I am sure many ER MDs are unfamiliar with. 

SCC Latin American Chapter led by Dr. Sandra Carrillo and Dr. Max Alzamora is spearheading some exciting projects to enhance the caliber of their cannabis programs.

The landscape of Latin America is rapidly advancing, and the SCC LATAM Chapter will be publishing cannabis science classes in Spanish. 

Most remarkable to me was Dr. Sherry Yafai’s palliative treatment of dementia. 5.8 million people in the United States have Alzheimer's disease and related dementias. Yafai presented four case studies where she recommended Nabilone, Dronabinol, or plant THC, CBD, and CBG-formulated products. All of her patients showed improvement in symptoms, one came out  of hospice care.

Variables affecting responses included age, cannabis product, and the length of time from initiation. It is imperative to focus on tapering down current pharmaceuticals with the corresponding titration up of cannabis. Research shows no efficacy with cannabis when the anti-seizure drugs were not simultaneously tapered down. This creates adverse events not related to cannabis, patience is required to successfully change drug protocols.  The best timeframe for revealing results is after four weeks. Presently in California, the family needs to administer cannabis medications in a medical institution.

A panel discussion of the obstacles patients experience, when their right to take a legal plant in a medical facility is prohibited. A typical Yafai treatment plan was: Average CBD: 120-127mg/week = 18 mg/day; Average THC: 52 - 55 mg/week = ~ 7-8 mg/day, a mix of inhaled and oral use was mentioned. The panel concluded that legalized cannabis is not enough, that there is an urgent need to implement the delivery of this miracle plant to everyone. Long-term use is prohibited when opioids are paid by the government with pennies on the dollar. We must combat the government’s War on Drugs propaganda. 

I’ve summarized the conference in this article but I do highly recommend the audio recording: listen to these outstanding physicians by clicking on this link and purchasing the webinar HERE.

Treating Covid -19 with CBDa:CBGa

By Billee Sharp

A few weeks ago I went down with my second Covid-19 infection.

Mercifully the symptoms, the sneezes, aching joints, loss of appetite and fatigue were not as severe as they were during my first infection with the Omicron variant a year ago.

The dominant variant in the U.S. currently is EG.5, a descendant of the Omicron variant. Omicron is no longer circulating and neither is the original Covid strain or the dangerous Alpha or Delta variants.

Nevertheless, EG.5 is a “variant of concern” according to the World Health Organisation. This is because EG.5 has a mutation which makes it significantly more contagious and potentially severe for vulnerable people.

I started taking Synergy’s Super Immune capsules after I had tested negative for the virus but while I was still experiencing symptoms, particularly fatigue and loss of appetite. I have been taking 50g daily and both my fatigue, which presented physically and cognitively and my lack of appetite began to recover immediately. I found that I could do more physically, even the massive basket of laundry! I also found my ability to concentrate on writing projects improved and my spirits lifted.

I’ve been doing a little research on the booster immunizations that are currently available as I have already had five doses of the vaccination since 2021 which seems like a lot!

So the current booster shot was developed to protect against the XBB.1.5 which is a closely related predecessor of EG.5. This indicates a good degree of protection as of the similar genetic coding of the sub variants of Omicron.

I’ve decided that I will continue to take the Super Immune capsules to prevent reinfection. The research shows the CBDa and CBGa block the spike protein of Covid virus’ and offer cellular protection from other RNA viruses like the common cold and influenza.

I’m very aware that my health relies on my immune system functioning and my ECS operating at full capacity. Taking CBDa and CBGa in full spectrum form has proved to be a huge support for my overall health.

Synergy Wellness has an ongoing sale on it’s Super Immune full spectrum capsules containing CBDa and CBGa, #241. Normally $75, these capsules are $60. We are extending the sale another month, till November 30th.